Browse categories and answer follow-up questions to refine your symptom profile.
Approach to the Critical Patient
Immediate stabilization
Stabilization priorities
Airway and breathing compromise
Altered mental status
Respiratory failure
Circulation threats
Hypotension
Shock physiology
Time critical triggers
Suspected sepsis from urinary source
Suspected obstructive uropathy with acute kidney injury
Suspected cauda equina syndrome
Initial actions
Bladder decompression pathway
Immediate catheterization for painful retention
Urology escalation if failed passage
Monitoring
Vital signs trend
Urine output after decompression
Analgesia and comfort
Topical urethral anesthetic
Systemic analgesia for severe pain
Key decision points
Risk stratification
High risk features
Fever
Flank pain
Rigors
Hypotension
New neurologic deficits
Obstructive complications
Hydronephrosis suspicion
Post obstructive diuresis risk
Traumatic catheterization risk
Blood at meatus
Pelvic trauma
Recent urethral instrumentation
PEARLS
Practical pearls
Bladder scan before catheter if uncertain diagnosis
Low bladder volume with inability to void suggests anuria rather than retention
Catheter drainage monitoring after decompression
High volume output with ongoing polyuria suggests post obstructive diuresis
Avoid repeated blind attempts if resistance
Urethral injury risk
Early urology involvement
History
Presenting features
Retention history
Symptom timeline
Sudden inability to void
Progressive voiding difficulty
Pain pattern
Suprapubic pain or pressure
Relief after drainage
Lower urinary tract symptoms
Weak stream
Hesitancy
Straining
Intermittency
Incomplete emptying
Nocturia
Urinary infection features
Dysuria
Frequency
Urgency
Fever
Risk factors and precipitants
Etiology clues
Outlet obstruction risks
Benign prostatic hyperplasia history
Prostate cancer history
Urethral stricture history
Pelvic malignancy history
Neurogenic risks
Diabetes mellitus neuropathy
Multiple sclerosis
Spinal cord injury
Recent spinal anesthesia
Back pain with neurologic symptoms
Medication triggers
Anticholinergics
Opioids
Sympathomimetics
Tricyclic antidepressants
Postoperative triggers
Recent surgery
Recent general anesthesia
Red flags
Emergency signals
Cauda equina features
Saddle anesthesia
New fecal incontinence
New urinary incontinence or retention
Bilateral sciatica
Progressive leg weakness
Trauma features
Pelvic fracture mechanism
Blood at urethral meatus
High riding prostate concern
Systemic toxicity
Rigors
Confusion
Persistent hypotension
Physical Exam
Focused examination
Exam domains
General appearance
Toxic appearance
Distress from pain
Abdominal exam
Suprapubic distention
Suprapubic tenderness
Peritoneal signs
Genitourinary exam
Phimosis or paraphimosis
Meatal stenosis
Blood at meatus
Scrotal swelling or tenderness
Neurologic exam
Lower extremity strength
Sensation including perineal
Reflexes
Gait when feasible
Rectal exam and pelvic exam
Targeted exams
Digital rectal exam findings
Prostate enlargement
Prostate tenderness
Reduced anal tone
Pelvic exam considerations
Pelvic organ prolapse in patients with vagina
Mass effect concern
PITFALLS
Common pitfalls
Reliance on suprapubic pain alone
Retention possible without pain in neurogenic bladder
Missing cauda equina syndrome
Back pain and urinary symptoms combination
Repeated catheter attempts despite resistance
False passage risk
Differential Diagnosis
Life threats and time sensitive diagnoses
Critical differential
Obstructive uropathy with acute kidney injury
Bilateral obstruction risk
Solitary kidney obstruction risk
Urosepsis
Obstructed infected system risk
Cauda equina syndrome ICD-10 G83.4
Urinary retention with neurologic findings
Spinal cord compression
Malignancy history
Epidural abscess risk
Common etiologies
Etiology categories
Benign prostatic hyperplasia ICD-10 N40.1
Most common in older men
Acute prostatitis ICD-10 N41.0
Fever and tender prostate
Urethral stricture ICD-10 N35.9
Prior instrumentation or STI history
Bladder neck obstruction
Post prostate procedure
Urolithiasis ICD-10 N20.0
Colicky pain
Constipation or fecal impaction ICD-10 K59.0
Rectal vault fullness
Medication induced urinary retention
Anticholinergic burden
Mimics
Not retention
Anuria
Bladder scan low volume
Acute kidney injury etiologies
Urinary incontinence with overflow
Constant dribbling
High post void residual
Laboratory Tests
Core testing
Initial labs
Urinalysis
Pyuria
Nitrites
Hematuria
Glucosuria
Urine culture
Fever or systemic symptoms
Suspected prostatitis
Serum creatinine and electrolytes
Obstructive acute kidney injury screening
Hyperkalemia risk
Complete blood count
Leukocytosis for infection concern
Anemia for gross hematuria
Point of care testing
Bedside tests
Glucose
Hyperglycemia associated neuropathy
Lactate
Shock or sepsis concern
Interpretation and pitfalls
Test limitations
Urinalysis
Pyuria can be sterile in obstruction
Hematuria nonspecific
Serum creatinine
Early obstruction can have normal creatinine
Prostate specific antigen
Not useful for acute decision making in the emergency setting
Diagnostic Tests
Scoring Systems
Structured assessments
International Prostate Symptom Score
Post acute episode outpatient severity assessment
Treatment response monitoring
Sepsis screening tools
qSOFA elements for rapid risk estimate
Limitations in sensitivity for early sepsis
MRI
MRI indications
Suspected cauda equina syndrome
Urinary retention with saddle anesthesia
Urinary retention with progressive weakness
Suspected spinal cord compression
Malignancy history with neurologic deficits
Suspected epidural abscess
Fever and back pain with neurologic symptoms
CT
CT indications
Suspected obstructing stone with complications
Fever or sepsis concern
Solitary kidney concern
Suspected malignancy or mass effect
Weight loss
Gross hematuria with clots
Trauma evaluation
Pelvic fracture patterns
Urethral injury pathway coordination
Ultrasound
Ultrasound applications
Bladder ultrasound
Post void residual estimation
Confirmation of retention before catheter
Renal ultrasound
Hydronephrosis evaluation
Post renal obstruction support
Point of care limitations
Mild hydronephrosis can be absent early
Bladder volume can be underestimated in obesity
Disposition
Admission and monitored care
Admit criteria
Sepsis or septic shock ICD-10 A41.9
Persistent hypotension
Lactate elevation
Acute kidney injury ICD-10 N17.9
Rising creatinine
Hyperkalemia
Post obstructive diuresis
Sustained high urine output after decompression
Electrolyte derangements
Gross hematuria with clots
Continuous bladder irrigation need
Hemodynamic instability
Neurologic emergency
Cauda equina syndrome concern
Spinal cord compression concern
Failed bladder drainage
Inability to pass urethral catheter
Suprapubic catheter requirement
Discharge planning
Discharge criteria
Stable vitals
No fever
No hypotension
Adequate drainage
Patent catheter with urine flow
Patient able to manage leg bag
No emergent imaging indication
No neurologic red flags
No suspected infected obstruction
Follow up arranged
Urology or primary care within 2 to 7 days
Trial without catheter plan
Treatment
Bladder drainage
Decompression strategy
Urethral catheter first line
Foley catheter 16 to 18 Fr for most adults
Lidocaine gel 2 percent intraurethral
Catheter selection adjustments
Suspected benign prostatic hyperplasia
Coudé catheter 16 to 18 Fr
Avoid force if resistance
Suspected urethral stricture
Smaller catheter 12 to 14 Fr
Single gentle attempt then escalation
Escalation for difficult catheterization
If resistance or pain then stop attempts
Urology consultation
Consider guidewire assisted placement by trained clinician
If urethral injury concern then avoid blind Foley
Retrograde urethrogram pathway
Suprapubic catheter by appropriate team
Drainage monitoring
Initial volume
Large initial output suggests prolonged retention
Post obstructive diuresis surveillance
Urine output hourly if high risk
Analgesia and supportive care
Comfort measures
Topical anesthetic
Lidocaine gel dwell time several minutes
Avoid excess volume in urethral trauma concern
Systemic analgesia
Acetaminophen PO for mild pain
NSAID PO or IV if renal function acceptable
Opioid sparing strategy when possible
Antiemetic therapy
Ondansetron PO or IV for nausea
Adjunct pharmacotherapy
Medical adjuncts
Alpha 1 blockers for suspected benign prostatic hyperplasia related retention
Tamsulosin
0.4 mg PO daily
Orthostatic hypotension risk
Cataract surgery history and floppy iris syndrome counseling
Alfuzosin
10 mg PO daily
QT prolongation caution
Silodosin
8 mg PO daily
Ejaculatory dysfunction risk
Antibiotics only for infection syndromes
Complicated urinary tract infection ICD-10 N39.0
Agent selection by local antibiogram
Culture directed adjustment
Acute bacterial prostatitis ICD-10 N41.0
Avoid prostatic massage
Admission threshold lower for toxicity
Trial without catheter planning
Catheter management plan
Short term indwelling catheter
Trial without catheter after 2 to 7 days for uncomplicated benign prostatic hyperplasia pattern
Alpha blocker continuation through trial
Immediate trial without catheter situations
Medication induced retention with clear reversible trigger
Postoperative retention with low risk features
Post obstructive diuresis management
Diuresis response
Diagnostic thresholds
Urine output greater than 200 ml per hour for 2 consecutive hours
Urine output greater than 3 l in 24 hours
Monitoring
Strict intake and output
Serum sodium and potassium trending
Fluid replacement
If ongoing diuresis then replace 50 to 75 percent of urine output with isotonic fluids
If hypotension then bolus and reassess
Electrolyte correction
Hypokalemia replacement per local protocol
Hypernatremia avoidance via appropriate fluid selection
Special Populations
Pregnancy
Pregnancy considerations
Etiologies
Uterine compression
Constipation
UTI prevalence increase
Diagnostics
Ultrasound preferred for hydronephrosis assessment
MRI for neurologic emergencies when indicated
Medications
Alpha blocker use only with obstetric consultation
Antibiotic selection pregnancy safe options when infection confirmed
Geriatric
Older adult considerations
Atypical presentation
Minimal pain in chronic high residual states
Delirium as infection presentation
Medication sensitivity
Orthostasis risk with alpha blockers
Anticholinergic burden review
Disposition
Lower threshold for admission with frailty
Home supports for catheter care
Pediatrics
Pediatric considerations
Etiologies
Constipation and functional retention
UTI and cystitis
Anatomic obstruction
Neurologic causes
Diagnostics
Bladder ultrasound for volume confirmation
Renal ultrasound if recurrent or complicated course
Catheterization
Weight and age appropriate catheter sizing
Child life support when available
Background
Epidemiology
Epidemiology summary
Acute urinary retention epidemiology
Increased incidence with age in patients with prostate enlargement
Common emergency department presentation
Common precipitants
Medication exposure
Alcohol intake
Constipation
Pathophysiology
Mechanisms
Outlet obstruction
Increased urethral resistance
Detrusor overwork and fatigue
Detrusor underactivity
Neuropathy related impaired contraction
Spinal cord pathway disruption
Complications of prolonged obstruction
Hydronephrosis
Post renal acute kidney injury
Post obstructive diuresis
Therapeutic Considerations
Treatment principles
Immediate bladder drainage
Standard of care based on expert consensus Class I recommendation
Pain relief and renal protection
Alpha blocker facilitation of trial without catheter
Improved likelihood of successful voiding after catheter removal
Guideline supported for benign prostatic hyperplasia related retention Class IIa recommendation
Avoidance of unnecessary antibiotics
Asymptomatic bacteriuria treatment avoidance
Culture guided therapy for infection syndromes
Patient Discharge Instructions
copy discharge instructions
Discharge instructions
Diagnosis and expectations
Urinary retention treated with catheter drainage
Catheter expected to stay in place until follow up plan
Catheter care
Keep drainage bag below bladder level
Secure tubing to leg to prevent pulling
Empty bag regularly and record output if instructed
Clean around catheter daily with soap and water
Medications
Take prescribed alpha blocker as directed
Avoid new antihistamines or anticholinergic cold medicines unless approved
Follow up
Urology or primary care appointment within 2 to 7 days
Trial without catheter plan at follow up
Return to emergency department immediately
No urine draining into bag for 2 hours with bladder discomfort
Catheter falls out
Fever
Shaking chills
Worsening flank pain
New weakness or numbness in legs
Numbness in groin or saddle area
New bowel incontinence
Large blood clots blocking catheter
Persistent vomiting
Dizziness or fainting
References
Clinical guidelines and evidence sources
Reference list
American Urological Association guidance on urinary retention and benign prostatic hyperplasia management
Alpha blocker use to improve trial without catheter success
Follow up evaluation for underlying obstruction
National Institute for Health and Care Excellence guidance on lower urinary tract symptoms in men
Assessment for complications and red flags
Shared decision making for catheter and follow up
International Continence Society terminology for urinary retention and post void residual concepts
Definitions for acute and chronic urinary retention
Post void residual measurement standards
Emergency medicine consensus recommendations
Immediate bladder decompression for painful acute retention Class I recommendation
Early urology consultation for difficult catheterization Class I recommendation
Coding references
Acute urinary retention ICD-10 R33.9
Other urinary retention ICD-10 R33.8
Benign prostatic hyperplasia with lower urinary tract symptoms ICD-10 N40.1
Urinary tract infection ICD-10 N39.0
Obstructive and reflux uropathy unspecified ICD-10 N13.9
Acute kidney failure unspecified ICD-10 N17.9
Cauda equina syndrome ICD-10 G83.4
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.